Fetal muscle-type nicotinic acetylcholine receptor (Fetal muscle AChR)

The fetal muscle-type nicotinic acetylcholine receptor is a ligand-gated ion channel present at the mammalian neuromuscular junction during fetal and early postnatal development. It is a heteropentamer composed of two α subunits, one β, one δ, and one γ subunit (α₂βγδ). This composition gives the fetal receptor distinct channel properties, including longer mean open time and higher affinity for acetylcholine compared to the adult (ε-subunit containing) form, and a lower conductance[3][5][1]. The fetal isoform plays key roles in clustering AChRs and organizing the pattern of neuromuscular innervation, as well as supporting embryonic muscle development[1][5]. The fetal receptor is gradually replaced by the adult ε-containing isoform after birth, although it can be re-expressed after denervation or injury[5]. Immunohistochemical or molecular detection of the γ-subunit distinguishes the fetal receptor and has diagnostic value in certain pediatric tumors, particularly rhabdomyosarcoma[2]. Abnormalities of the fetal AChR, due either to genetic defects or maternal antibodies, underlie congenital and autoimmune myasthenic syndromes and rare fetal myopathies[3][4]. It is selectively targeted by certain drugs and autoantibodies, and is a candidate for both therapeutic and diagnostic targeting in pediatric muscle tumors and neuromuscular diseases[2][4].

Other names

Fetal AChRfetal nicotinic acetylcholine receptormuscle fetal-type acetylcholine receptornAChR (fetal)α2βγδ acetylcholine receptor

Agonists (e.g., acetylcholine, succinylcholine) bind and activate the ion channel, allowing sodium influx and muscle contraction; Antagonists (e.g., d-Tubocurarine) block the channel and prevent neuromuscular transmission; Antibodies can inactivate the receptor by crosslinking, internalization, and degradation